Synergistic Anti-inflammatory Composition with Omega-3 and Lycopene
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current natural product compositions for inhibiting nitric oxide (NO) production have limited efficacy and potency in managing inflammatory disorders, necessitating the development of more effective formulations.
Innovation Solution
A synergistic composition combining omega-3 fatty acids (EPA and DHA), lycopene, lutein, and carnosic acid, with specific molar concentration ratios, which is effective in inhibiting NO production and exhibiting anti-inflammatory effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural product compositions (such as lutein or lycopene alone) are used to inhibit NO production, then the composition has natural origin and safety, but the efficacy and potency are not particularly high
Solution Approach 1:
The patent combines multiple natural products (omega-3 fatty acids EPA and DHA, lycopene, lutein, and carnosic acid) into a single composition. This merging of multiple natural ingredients with complementary mechanisms of action synergistically enhances the inhibition of NO production and inflammatory mediators, thereby improving efficacy and potency while maintaining natural origin
Solution Approach 2:
The invention creates a composite natural product formulation where omega-3 fatty acids, carotenoids (lycopene and lutein), and phenolic compounds (carnosic acid) work together. This composite approach leverages the synergistic interactions between different natural compounds to achieve superior anti-inflammatory effects compared to individual natural products
2Reliability
If a synergistic combination of multiple compounds is used, then the anti-inflammatory efficacy is enhanced, but the composition complexity increases
Solution Approach 1:
Each ingredient in the composition serves multiple functions: omega-3 fatty acids provide anti-inflammatory effects and cell membrane stability, lycopene and lutein offer antioxidant protection and NF-κB pathway modulation, and carnosic acid provides additional antioxidant and anti-inflammatory actions. This multi-functionality allows the composition to achieve enhanced efficacy through several complementary mechanisms simultaneously
Solution Approach 2:
The patent specifies optimized concentration ranges for each ingredient (EPA: 10-500 mg, DHA: 10-500 mg, lycopene: 1-50 mg, lutein: 1-50 mg, carnosic acid: 1-50 mg) to achieve synergistic effects. By carefully controlling the parameters of ingredient concentrations, the composition maximizes anti-inflammatory efficacy while managing complexity through defined formulation specifications
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 2C~2D
AI summary
This invention is directed to compositions having synergistic combinations of omega-3 fatty acid such as OMEGA-3 with a tomato extract lycopene, and optionally with carnosic acid and/or lutein. More specifically, the present invention provides compositions having synergistic combinations of the aforementioned compounds, which may be used, inter alia, to inhibit/suppress inflammation via the suppression of the expression of anti-inflammatory mediators or via the suppression of the secretion of anti-inflammatory mediators from macrophages at a site of inflammation.